Medscape: The Gold Standard in Medical Content. Now powered by AI.
1:27
YouTubeMedscape
Medscape: The Gold Standard in Medical Content. Now powered by AI.
Millions of physicians like Dr. Akua Ampadu trust Medscape globally. Now, with AI, that trusted expertise delivers fairness, accuracy, and transparency at scale. Try it here: https://www.medscape.com/ai-search?query=What are the patterns of drug-induced liver injury with GLP-1 agonists?&ecd=soc_yt_251211_vid_medscapeai_ampadu #paid #medscapeai ...
248 views6 days ago
Medscape News
Breaking News in IBD: Advancing Confidence in Optimizing Subcutaneous Anti-TNF Treatment Across the Care Continuum | Medscape
Breaking News in IBD: Advancing Confidence in Optimizing Subcutaneous Anti-TNF Treatment Across the Care Continuum | Medscape
FacebookMedscape
637 views1 month ago
The Truth About Vaping
The Truth About Vaping
medscape.com
Dec 11, 2023
New Injectable Weight Loss Drugs Pose Ethical Issues
New Injectable Weight Loss Drugs Pose Ethical Issues
medscape.com
Feb 1, 2024
Top videos
Medscape AI: Insight grounded in experience
1:29
Medscape AI: Insight grounded in experience
YouTubeMedscape
1 views23 hours ago
RET Gene Testing in Medullary Thyroid Cancer
40:41
RET Gene Testing in Medullary Thyroid Cancer
YouTubeMedscape
2 days ago
Dec 05 2025 This Week in Cardiology
29:58
Dec 05 2025 This Week in Cardiology
YouTubeMedscape
207 views1 week ago
Medscape CME Courses
Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape
0:32
Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape
FacebookMedscape
71 views1 week ago
Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape
Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape
FacebookMedscape
382 views2 months ago
Implicit Bias: It's in All of Us
Implicit Bias: It's in All of Us
medscape.com
Feb 7, 2018